Optical Coherence Tomography (OCT) for Ophthalmology Global Market Report 2022: Featuring Key Players Canon, Novacam Technologies, Thorlabs & Others

DUBLIN, July 14, 2022 /PRNewswire/ — The “Optical Coherence Tomography (OCT) for Ophthalmology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Optical Coherence Tomography (OCT) for Ophthalmology was estimated at US$526.2 Million in the year 2020, and is projected to reach a revised size of US$754.4 Million by 2026, growing at a CAGR of 6.3% over the analysis period. Conventional OCT Systems, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$667.4 Million by the end of the analysis period.   

Global Optical Coherence Tomography (OCT) for Ophthalmology Market to Reach $754.4 Million by the Year 2026
Optical coherence tomography (OCT), a non-invasive, diagnostic technology is fast becoming an established imaging technology in ophthalmic diagnosis. OCT relies on light waves for capturing high-quality 3D retinal images in a non-invasive manner, enabling medical professionals to study eye conditions.

An aging population, growing prevalence of ocular diseases, rapid increase in diabetic population and increasing focus on curbing healthcare expenditures continue to drive the demand for ophthalmic diagnostic equipment. With rise in the average life span, there is an increasing incidence of ophthalmic and ocular conditions which is a natural phenomenon of aging.

In addition, lifestyle trends and rising levels of pollution in developed and developing countries have put an ever-increasing number of people at risk of developing potential eye allergies, hypersensitivity to environmental elements such as pollen, dust, and dry eye syndrome among others. A key trend in the space is integration of various devices into single equipment. The ongoing shift to spectral domain OCT technology from time domain OCT is spurring growth in the market.

Spectral domain OCT, an advancement in imaging technology enables efficient examination of ocular pathologies. Further infusing growth into the segment is the integration of built in devices such as fundus cameras and OCT scanning laser ophthalmoscopes. Software upgrades in OCT systems are introducing advanced disease-progression analysis featuring greater range in data capture and imaging.

The U.S. Market is Estimated at $169.9 Million in 2021, While China is Forecast to Reach $96.9 Million by 2026
The Optical Coherence Tomography (OCT) for Ophthalmology market in the U.S. is estimated at US$169.9 Million in the year 2021. The country currently accounts for a 30.97% share in the global market.

China, the world`s second largest economy, is forecast to reach an estimated market size of US$96.9 Million in the year 2026 trailing a CAGR of 9.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 6.1% respectively over the analysis period. 

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Optical Coherence Tomography (OCT): An Introduction
  • Outlook: Focus on Preventative Healthcare to Improve Demand
  • Developing Markets Drive Momentum
  • Rise in Incidence of Ocular Diseases Drive Demand for OCT Devices
  • Key Ophthalmic Disease Statistics
  • Prevalence of Adult Vision Impairment and Age-Related Eye Diseases in the US
  • Global Causes of Visual Impairment: Percentage Breakdown by Number of Cases
  • Recent Industry Activity
  • World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Adaptive Optics & OCT Achieve High-Resolution In-Vivo Retinal Imaging
  • Enhancing Retinal Imaging Quality
  • Ongoing Efforts to Improve Imaging
  • Handheld Devices to Extend Clinical Acceptance of Optical Coherence Tomography
  • Handheld OCT Devices Set to Make Big Gains
  • Advances in OCT Systems for High-Quality Imaging of Anterior Segment of Eye
  • OCT Angiography: A Growing Market with High Potential
  • Intraoperative OCT Gains Importance as Valuable Tool for Image-Guided Surgical Care
  • Intraoperative OCT Appears Poised to Transform Surgical Ophthalmic Care Domain
  • Growing Incidence of Diabetic Retinopathy Unfolds Significant Opportunities
  • OCT Revolutionizes Clinical Management of Diabetic Macular Edema
  • Rising Prevalence of Diabetes Fuels Growth
  • Growing Role of OCT in Evaluating Optic Neuropathies Bodes Well
  • Combo OCT/Fundus Systems Widen Opportunities in Ophthalmology
  • At-Home OCT Emerges as New Growth Vertical
  • Integration of OCT in Surgical Microscopy: The Ongoing Trend
  • OCT Devices Gain Demand as Diagnostic Application of Lasers Gain Significant Attention
  • OCT Evolves as an Important Tool in Glaucoma Management
  • Optical Coherence Tomography to Offer Significant Insights into AMD Progression
  • Deep Learning Algorithms Step In to Widen the Scope & Span of OCT
  • Spectral-Domain OCT for Prognostication & Management of Retinal Pathologies
  • Rise in Aging Population Drives Demand

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

 Companies Mentioned

  • Canon Inc.
  • Carl Zeiss AG
  • Heidelberg Engineering GmbH
  • Leica Microsystems GmbH
  • Nidek Co. Ltd.
  • Novacam Technologies, Inc.
  • Optopol Technology Sp. z o.o.
  • Optovue, Inc.
  • Thorlabs, Inc.
  • Tomey Corporation
  • Topcon Corporation

For more information about this report visit https://www.researchandmarkets.com/r/cv36d6

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://healthtechnologynet.com/wp-content/uploads/2022/07/Research_and_Markets_Logo-1.jpg

View original content:https://www.prnewswire.com/news-releases/optical-coherence-tomography-oct-for-ophthalmology-global-market-report-2022-featuring-key-players-canon-novacam-technologies–thorlabs–others-301586602.html

SOURCE Research and Markets

Staff

Recent Posts

Syngene launches platform for rapid, enhanced protein production

The new proprietary cell line development platform combines a robust cell line, transposon technology with…

36 mins ago

Stanford Blood Donor Center Chooses the HemoFlow 500 and HemoVue Cloud Service to Streamline Its Whole Blood Collection Operations

GRASS VALLEY, CA / ACCESSWIRE / June 4, 2024 / Applied Science, the worldwide leader…

4 hours ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

6 hours ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

6 hours ago

AffableBPM names Greg Chavers as new Chief Revenue & Sales Officer to drive innovation in healthcare automation

SEATTLE, June 4, 2024 /PRNewswire/ -- AffableBPM, a leader in AI-powered business process automation for…

7 hours ago